Welcome to EBE, the Voice of Biopharmaceuticals in Europe

All stakeholders should stand to benefit from the advances in healthcare that biopharmaceutical technology offers and they all have a role to play. EBE has become a key focal point for information exchange between the research-based biopharmaceutical industry operating in Europe and all major stakeholders engaged in this process.

Biotechnology is delivering significant advances in human healthcare. Entirely new medicines are being created, notably for rare or previously untreated diseases. Biotech production methods provide safer versions of existing treatments in unlimited quantities. Biotechnology has revolutionised the research and development of new medicines and allows better product targeting for specific diseases and patient groups. A greater understanding of the genetic causes of disease allows early detection and treatment, and the new field of gene therapy may even herald the possibility to cure diseases, not simply treat them.

Current Issues

EBE Annual Meetings 2012

EBE will hold its Annual Meetings 2012 on 26 June, in Brussels. The events are organised in conjunction with EFPIA.

As you might know, EBE Members also have the opportunity to attend meetings of the EFPIA Annual Programme, scheduled for 26 and 27 June in Brussels. You will receive a full programme and a specific registration form from EFPIA, in due course.
Please find attached an initial description of the EBE Annual Meetings this year and the registration form for the EBE events. Please make sure to send your completed individual registration form by the set deadline.

more

"Innovation in Healthcare without borders" Conference

The European Commission (DG Research and Innovation, DG Enterprise and Industry, DG Health and Consumers, DG for Regional Policy) organised a conference on "Innovation in Healthcare without borders", in consultation with other relevant DGs, major health associations and stakeholders on 16-17 April at Flagey, Brussels. This event  was supported by EBE.  

This Conference was set up as an innovation in healthcare policy forum involving key actors and policy-makers. It aimed at identifying major challenges and building consensus whilst developing initiatives and opportunities for Healthcare Innovation.

more

IMI Info Day- 5th call proposals (Brussels, 27 February 2012)

The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership that fosters improvement of the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. This €2 billion-budget initiative supports collaborative research projects in addition to building networks of industrial and academic experts in Europe that will boost innovation in healthcare.

more

European Commission Action Plan to improve access to finance for SMEs

The European Commission has disclosed its action plan to improve access to finance for SMEs.  http://ec.europa.eu/enterprise/policies/finance/files/com-2011-870_en.pdf 
 
In this document, the Commission acknowledges the difficulties faced by SMEs in obtaining the financing they need to develop their activities.  It also stresses the crucial role for a healthy financial system to support growth, notably for SMEs.

We invite you to carefully read this document that will be discussed intensively within EBE relevant committees and tasks forces.  However, we would like to emphasise the following items:

more
  • Members Login
  • Join EBEclick here for more information